Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- I. Litvan, J. Goldman, M. Emre
- Psychology, MedicineMovement Disorders
- 1 March 2012
These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage.
Clinical diagnostic criteria for dementia associated with Parkinson's disease
- M. Emre, D. Aarsland, B. Dubois
- Psychology, MedicineMovement Disorders
- 15 September 2007
Clinical diagnostic criteria for probable and possible PD‐D are proposed, characterized by impairment in attention, memory, executive and visuo‐spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent.
Diagnosis and management of dementia with Lewy bodies
- I. McKeith, D. Dickson, M. Yamada
- Medicine, PsychologyNeurology
- 27 December 2005
The authors propose a new scheme for the pathologic assessment of LBs and Lewy neurites (LN) using alpha-synuclein immunohistochemistry and semiquantitative grading of lesion density, with the pattern of regional involvement being more important than total LB count.
Rivastigmine for dementia associated with Parkinson's disease.
- M. Emre, D. Aarsland, R. Lane
- Medicine, PsychologyNew England Journal of Medicine
- 9 December 2004
Rivastigmine was associated with moderate improvements in dementia associated with Parkinson's disease but also with higher rates of nausea, vomiting, and tremor; however, the differences between these two groups were moderate and similar to those reported in trials of rivastIGmine for Alzheimer's disease.
Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
The main focus of this article is to operationalize the diagnosis of PD‐D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment.
Dementia associated with Parkinson's disease
- M. Emre
- Psychology, BiologyLancet Neurology
- 1 April 2003
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study
- I. McKeith, T. Ser, R. Spiegel
- Medicine, PsychologyThe Lancet
- 16 December 2000
Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress
- D. Aarsland, K. Brønnick, J. Cummings
- Psychology, MedicineJournal of Neurology Neurosurgery & Psychiatry
- 4 July 2006
Neuropsychiatric symptoms are common in patients with PDD and may be associated with distinct neurobiological changes, which should be explored in future studies.
Mild cognitive impairment in Parkinson disease
- D. Aarsland, K. Brønnick, M. Emre
- Psychology, MedicineNeurology
- 21 September 2010
Having MCI was associated with older age at assessment and at disease onset, male gender, depression, more severe motor symptoms, and advanced disease stage, and future studies of patients with PD with MCI need to determine risk factors for ongoing cognitive decline and assess interventions at a predementia stage.
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
- G. Waldemar, B. Dubois, B. Winblad
- Medicine, PsychologyEuropean Journal of Neurology
- 1 January 2007
This international guideline on dementia covers major aspects of diagnostic evaluation and treatment, with particular emphasis on the type of patient often referred to the specialist physician, and revised the recommendations for clinical diagnosis, blood tests, neuroimaging, electroencephalography, and cerebrospinal fluid analysis.
...
...